CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases.

Sophie Brisset , Gudrun Schleiermacher , Martine Peter , Aline Mairal
Cancer Genetics and Cytogenetics 130 ( 1) 57 -61

39
2001
Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma.

Gudrun Schleiermacher , Isabelle Janoueix-Lerosey , Valérie Combaret , Josette Derré
Cancer Genetics and Cytogenetics 141 ( 1) 32 -42

53
2003
LIN7A is a major determinant of cell-polarity defects in breast carcinomas

Nadège Gruel , Laetitia Fuhrmann , Catalina Lodillinsky , Vanessa Benhamo
Breast Cancer Research 18 ( 1) 23 -23

8
2016
High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma.

Caroline Louis-Brennetot , Olivier Delattre , Isabelle Janoueix-Lerosey ,
EBioMedicine 53 102702

2020
Induction of p21Waf1/Cip1 by TNFα requires NF-κB activity and antagonizes apoptosis in Ewing tumor cells

Delphine Javelaud , Juana Wietzerbin , Olivier Delattre , Françoise Besançon
Oncogene 19 ( 1) 61 -68

64
2000
A new member of the ETS family fused to EWS in Ewing tumors

Martine Peter , Jérome Couturier , Hélène Pacquement , Jean Michon
Oncogene 14 ( 10) 1159 -1164

337
1997
Molecular profiling of patient-derived breast cancer xenografts

Fabien Reyal , Charlotte Guyader , Charles Decraene , Carlo Lucchesi
Breast Cancer Research 14 ( 1) 1 -14

136
2012
Polarity gene alterations in pure invasive micropapillary carcinomas of the breast

Nadège Gruel , Vanessa Benhamo , Jaydutt Bhalshankar , Tatiana Popova
Breast Cancer Research 16 ( 3) 1 -15

21
2014
Embryonal tumor with multilayered rosettes: diagnostic tools update and review of the literature.

Johnatan Ceccom , Franck Bourdeaut , Najat Loukh , Valerie Rigau
Clinical Neuropathology 33 ( 1) 15 -22

33
2014
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

Anne Vincent-Salomon , Nadège Gruel , Carlo Lucchesi , Gaëtan MacGrogan
Breast Cancer Research 9 ( 2) 1 -15

149
2007
Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens.

Isabelle Hostein , Marie Andraud-Fregeville , Louis Guillou , Marie-José Terrier-Lacombe
Cancer 101 ( 12) 2817 -2824

59
2004
Abstract A29: Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas

Julien Calderaro , Julien Masliah-Planchon , Wilfrid Richer , Laetitia Planque
Cancer Research 76

2016
Abstract IA02: Identity shifts in pediatric cancers

Olivier Delattre , GA Franzetti , K Laud-Duval , A Brisac
Cancer Research 78

2018
Abstract B78: Role of noradrenergic core regulatory circuitry transcription factors in neuroblastoma cell identity

Agathe Peltier , Caroline Louis-Brennetot , Cécile Pierre-Eugène , Cécile Thirant
Cancer Research 80

2020
Abstract B68: Spatial and temporal conditions for Smarcb1 deletion determines mouse AT/RT (atypical teratoid/rhabdoid tumor) subtype

Zhi-Yan Han , Mamy Andrianteranagna , Maria Jesus-Lobon-Iglesias , Arnault Tauziède-Espariat
Cancer Research 80

2020